Comment on Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. [JAMA Oncol. 2016
This systematic review explored the neurobiological mechanisms underlying the clinical time course o...
Chemotherapy is associated with cognitive impairment in a subgroup of breast cancer survivors, but t...
Chemotherapy-related cognitive impairments (CRCIs) are commonly self-reported among cancer patients,...
Purpose: Women treated for breast cancer often experience cognitive complaints. We studied whether l...
Several studies in cancer research have suggested that cognitive dysfunction following chemotherapy,...
Complaints of reduced cognitive abilities are frequent following chemotherapy. Research in the breas...
PURPOSE:Treatment modalities for breast cancer, the leading cause of cancer-related deaths in women ...
Cognitive impairment is a common toxicity of cancer treatment. A better understanding of changes in ...
Purpose: A subgroup of patients with breast cancer suffers from mild cognitive impairment after chem...
Thanks to earlier diagnosis and improved cancer treatments, the survival rate of breast cancer patie...
OBJECTIVES: To review neuroimaging research concerning cancer- and cancer treatment-related chang...
Abstract Purpose Subsequent to chemotherapy treatment...
Target Audience Researchers and Clinician/Scientists interested in the longitudinal effects of chemo...
BACKGROUND:Cognitive problems in breast cancer patients are common after systemic treatment, particu...
In addition to the burden of a life-threatening diagnosis, cancer patients are struggling with adver...
This systematic review explored the neurobiological mechanisms underlying the clinical time course o...
Chemotherapy is associated with cognitive impairment in a subgroup of breast cancer survivors, but t...
Chemotherapy-related cognitive impairments (CRCIs) are commonly self-reported among cancer patients,...
Purpose: Women treated for breast cancer often experience cognitive complaints. We studied whether l...
Several studies in cancer research have suggested that cognitive dysfunction following chemotherapy,...
Complaints of reduced cognitive abilities are frequent following chemotherapy. Research in the breas...
PURPOSE:Treatment modalities for breast cancer, the leading cause of cancer-related deaths in women ...
Cognitive impairment is a common toxicity of cancer treatment. A better understanding of changes in ...
Purpose: A subgroup of patients with breast cancer suffers from mild cognitive impairment after chem...
Thanks to earlier diagnosis and improved cancer treatments, the survival rate of breast cancer patie...
OBJECTIVES: To review neuroimaging research concerning cancer- and cancer treatment-related chang...
Abstract Purpose Subsequent to chemotherapy treatment...
Target Audience Researchers and Clinician/Scientists interested in the longitudinal effects of chemo...
BACKGROUND:Cognitive problems in breast cancer patients are common after systemic treatment, particu...
In addition to the burden of a life-threatening diagnosis, cancer patients are struggling with adver...
This systematic review explored the neurobiological mechanisms underlying the clinical time course o...
Chemotherapy is associated with cognitive impairment in a subgroup of breast cancer survivors, but t...
Chemotherapy-related cognitive impairments (CRCIs) are commonly self-reported among cancer patients,...
DOI
Add to ORKG